Status:
UNKNOWN
Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Pregnancy
Diabetes Mellitus
Eligibility:
FEMALE
18-45 years
Brief Summary
The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigato...
Detailed Description
In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventiona...
Eligibility Criteria
Inclusion
- All consequtive pregnant women
- with Diabetes Mellitus - Gestational and non Gestational
Exclusion
- .No willing to participate.
- Suspected Heart anomaly
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01845324
Start Date
May 1 2013
End Date
June 1 2014
Last Update
May 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100